Back to search

United Kingdom· GB-APID-21908911000001105

Cyclizine 50mg tablets

A cyclizine product containing cyclizine, registered in United Kingdom by Teva UK Ltd. The same ATC class is registered in 5 of our 19 countries.

ATC R06AE03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCyclizine 50mg tabletsATCR06AE03REGISTER NO.GB-APID-2190891100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Cyclizine is registered in 5 of 19 countries.

Countries holding a registration under ATC R06AE03 (cyclizine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 2 of them publish a price we can compare per daily dose

Cyclizine · ATC R06AE03

5 / 19 countries

  • Denmark
  • Finlandprice
  • Ireland
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Cyclizine
Manufacturer
Teva UK Ltd
Country
United Kingdom (GB)
ATC code
R06AE03
ATC class
Cyclizine
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5017007025474

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

265 interactions on record for cyclizine.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cyclizine · interactions on record

265 records

  • 9 severe
  • 253 moderate
  • 3 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • Sodium oxybateN01AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyclizine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyclizine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Denmark · Gotur, Marzine
  • Finland · Marzine
  • Ireland · Valoid
  • Norway · Marzine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e64babce-fa2f-4a8a-8713-eaffa9edb423
GET /v1/drugs/e64babce-fa2f-4a8a-8713-eaffa9edb423?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "21908911000001105",
  "desc": "Cyclizine 50mg tablets (Teva UK Ltd)",
  "form": "Oral tablet",
  "vpid": "42034511000001109",
  "source": "dmd",
  "vtm_id": "775411003",
  "strength": "50 mg",
  "substance": "Cyclizine",
  "ingredient": "Cyclizine hydrochloride",
  "supplier_code": "3849901000001105"
}

See everything about cyclizine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.